Antivert

Pellagra, Hardening of the Arteries, dietary supplementation + 14 more

Treatment

8 FDA approvals

20 Active Studies for Antivert

What is Antivert

Niacin

The Generic name of this drug

Treatment Summary

Meclizine is a medication that helps to reduce the symptoms of motion sickness and vertigo. It works by blocking histamine in the brain, and can also have calming effects on the central nervous system. Meclizine is generally prescribed to be taken orally as tablets, and is available under the brand name Antivert in the U.S.

O-Cal FA multivitamin

is the brand name

image of different drug pills on a surface

Antivert Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

O-Cal FA multivitamin

Niacin

1970

106

Approved as Treatment by the FDA

Niacin, also known as O-Cal FA multivitamin, is approved by the FDA for 8 uses which include High Cardiovascular Risk and Hyperlipidemia .

High Cardiovascular Risk

Used in combination with other therapies

Hyperlipidemia

Used in combination with Sevelamer to help manage Hyperlipidemias

Hardening of the Arteries

Used in combination with Sevelamer to help manage Atherosclerosis

High Cholesterol

Used in combination with Sevelamer to help manage Hyperlipidemias

Coronary Artery Disease

Used in combination with Sevelamer to help manage history of coronary artery disease

dietary supplementation

Used in combination with Niacin for dietary supplementation

Primary Hypercholesterolemia

Used in combination with other therapies

Dietary Modifications

Used in combination with other therapies

Effectiveness

How Antivert Affects Patients

Meclizine is used to reduce nausea, vomiting, or dizziness, particularly caused by motion sickness or problems with the vestibular system. It usually starts working within an hour and can last up to 24 hours. Meclizine can cause drowsiness due to its effects on the brain.

How Antivert works in the body

Vomiting is a reflex that is regulated by an area in the brain called the CTZ. This area sends signals to another area called the vomiting center. Different receptors, such as histamine, serotonin, and dopamine, are found in the brainstem and can trigger a vomiting response. Meclizine works by blocking the histamine receptors in the vestibular nuclei and the nucleus of the solitary tract, thus preventing signals from reaching the vomiting center. Meclizine may also reduce stimulation of the area that controls balance and coordination.

When to interrupt dosage

The advised dose of Antivert is contingent upon the determined affliction, such as Disease, Vertigo and Airsickness. The amount of dosage is dependent on the method of delivery outlined in the table below.

Condition

Dosage

Administration

Coronary Artery Disease

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Combined Modality Therapy

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Dietary Modifications

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Risk of pancreatitis

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

inadequate response to diet

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Hypertriglyceridemia

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

High Cholesterol

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Hardening of the Arteries

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

dietary supplementation

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Primary Hypercholesterolemia

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

cholesterol

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Myocardial Infarction

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Hyperlipidemias

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Triglycerides

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Dyslipidemias

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Pellagra

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

High Cardiovascular Risk

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet, Tablet - Oral, Capsule, Liquid - Oral, Topical, Shampoo, Shampoo - Topical, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Solution, Liquid, Capsule, extended release, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Powder - Oral, Powder, Tablet, chewable, Tablet, chewable - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Solution / drops - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Kit - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral, Kit

Warnings

Antivert Contraindications

Condition

Risk Level

Notes

Hypervitaminosis

Do Not Combine

Liver Dysfunction

Do Not Combine

Transaminases

Do Not Combine

Hemorrhage

Do Not Combine

Liver Diseases

Do Not Combine

Peptic Ulcer

Do Not Combine

Transaminases

Do Not Combine

There are 20 known major drug interactions with Antivert.

Common Antivert Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Niacin.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Niacin.

Acenocoumarol

Major

The metabolism of Acenocoumarol can be decreased when combined with Niacin.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Niacin.

Alpelisib

Major

The metabolism of Alpelisib can be decreased when combined with Niacin.

Antivert Toxicity & Overdose Risk

The lowest toxic dose of meclizine in mice has been found to be 1600mg/kg when administered orally and 625mg/kg when administered intraperitoneally. In rats, the lowest toxic dose is 800mg/kg when administered orally. Symptoms of overdose may include extreme drowsiness, coma, seizures, and low blood pressure (especially in the elderly). In children, overdose may produce anticholinergic effects and hallucinations. Treatment for meclizine overdose includes supportive care and, if taken recently, inducing vomiting or using a gastric lavage to limit further absorption. Physostigmine may be used to counteract

image of a doctor in a lab doing drug, clinical research

Antivert Novel Uses: Which Conditions Have a Clinical Trial Featuring Antivert?

10 active trials are presently investigating the potential of Antivert to mitigate Disease, Airsickness and Vertigo symptoms.

Condition

Clinical Trials

Trial Phases

Coronary Artery Disease

0 Actively Recruiting

dietary supplementation

0 Actively Recruiting

High Cholesterol

19 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Early Phase 1

Dyslipidemias

1 Actively Recruiting

Phase 2

Pellagra

0 Actively Recruiting

cholesterol

4 Actively Recruiting

Phase 3, Not Applicable

Hyperlipidemias

0 Actively Recruiting

Risk of pancreatitis

0 Actively Recruiting

Hardening of the Arteries

17 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 3

Primary Hypercholesterolemia

8 Actively Recruiting

Phase 2, Phase 3, Not Applicable

Combined Modality Therapy

0 Actively Recruiting

High Cardiovascular Risk

1 Actively Recruiting

Phase 3

Dietary Modifications

3 Actively Recruiting

Early Phase 1, Not Applicable, Phase 2

Triglycerides

0 Actively Recruiting

Hypertriglyceridemia

6 Actively Recruiting

Phase 3, Phase 2

Myocardial Infarction

0 Actively Recruiting

inadequate response to diet

0 Actively Recruiting

Antivert Reviews: What are patients saying about Antivert?

5

Patient Review

10/26/2013

Antivert for Sensation of Spinning or Whirling

I unfortunately did not experience any relief from my vertigo after using this medication.

5

Patient Review

2/3/2012

Antivert for Sensation of Spinning or Whirling

4.7

Patient Review

3/3/2012

Antivert for Sensation of Spinning or Whirling

4.7

Patient Review

4/26/2012

Antivert for Sensation of Spinning or Whirling

4.3

Patient Review

2/3/2016

Antivert for Sensation of Spinning or Whirling

This medication always makes me sleepy, but it's really effective when I'm in a lot of pain and can't walk because of dizziness. I've been using it for 15 years, only as needed.

4.3

Patient Review

4/30/2016

Antivert for Sensation of Spinning or Whirling

I've had vertigo three times now and this medication always seems to help. However, I do get very drowsy after taking it.

4

Patient Review

3/31/2013

Antivert for Sensation of Spinning or Whirling

I have vertigo that comes and goes, and I'm not sure if this drug helps with that or not. However, I do know that it makes me feel incredibly sleepy to the point where I can't function.

4

Patient Review

3/29/2013

Antivert for Sensation of Spinning or Whirling

I have had this problem for 40 years and, unfortunately, this treatment did not help.

3

Patient Review

1/25/2016

Antivert for Sensation of Spinning or Whirling

These pills work well to keep spinning-induced nausea at bay, but they make me very drowsy.

2.3

Patient Review

12/13/2011

Antivert for Sensation of Spinning or Whirling

2.3

Patient Review

7/26/2012

Antivert for Sensation of Spinning or Whirling

This treatment helps me when I'm feeling vertigo, though it's not a perfect solution.

2

Patient Review

11/30/2011

Antivert for Sensation of Spinning or Whirling

1.7

Patient Review

11/27/2015

Antivert for Sensation of Spinning or Whirling

Though it does help with vertigo, this medication unfortunately also very significantly impairs my energy levels and motivation.

1

Patient Review

10/28/2014

Antivert for Sensation of Spinning or Whirling

Meclizine did nothing to help with my dizzy spells. If anything, they got worse when I was taking the medication. I only found relief after quitting the meds and flushing them out of my system.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about antivert

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Antivert sold over the counter?

"Antivert and Bonine are both available to purchase, however Antivert is only obtainable through a prescription whereas Bonine can be bought over-the-counter. They have similar side effects such as blurred vision, dry mouth and drowsiness, however Antivert also has constipation, dizziness, headache, vomiting and tiredness as additional side effects."

Answered by AI

How long does it take for Antivert to work for vertigo?

"The bottom line is that meclizine can be used to treat vertigo or nausea and vomiting caused by motion sickness. However, it takes about an hour to start working and may cause drowsiness, although it is less likely to cause drowsiness than some other antihistamines."

Answered by AI

What does Antivert do for vertigo?

"Antivert is a medication used to prevent or treat nausea, vomiting, and dizziness caused by motion sickness. It may also be used to reduce lightheadedness, dizziness, and loss of balance (vertigo) caused by diseases that affect the inner ear."

Answered by AI

What is the medication Antivert used for?

"Meclizine is an antihistamine that is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It may also be used to reduce dizziness and loss of balance (vertigo) caused by inner ear problems."

Answered by AI

Clinical Trials for Antivert

Image of University of Alberta in Edmonton, Canada.

Pharmacist-led Care for Diabetes

18+
All Sexes
Edmonton, Canada

As of 2024, nine percent of Albertans are living with Type 2 diabetes, which increases their risk for cardiovascular disease, stroke, blindness, and kidney failure. Unfortunately, less than half of patients have controlled Type 2 diabetes. We are well aware of the factors which lead to worsening diabetes, but need to give people more support to help them manage their diabetes. Pharmacists are respected health care professionals who are often easier to see that doctors and can help people with diabetes to stay as healthy as possible. This research project aims to see whether a pharmacist service can help improve diabetes management in people with type 2 diabetes compared to usual care from their family physician or nurse practitionner. The potential impact of this project is to empower people with type 2 diabetes to understand their condition, it's management, and to achieve target blood sugar levels, which will ultimately reduce the risk of diabetes-related complications.

Recruiting
Has No Placebo

University of Alberta

Ross Tsuyuki, BScPharm, PharmD, MSc

Have you considered Antivert clinical trials?

We made a collection of clinical trials featuring Antivert, we think they might fit your search criteria.
Go to Trials
Image of Lipid Clinic at Brown University Health in Providence, United States.

2-HOBA Supplementation for High Cholesterol

18 - 69
All Sexes
Providence, RI

The goal of this clinical trial is to learn if a natural supplement called 2-hydroxybenzylamine (2-HOBA) can reduce harmful oxidized lipids and improve the function of lipoprotein(a) in adults with high lipoprotein(a) levels. The main questions it aims to answer are: Does 2-HOBA lower oxidized phospholipids on lipoprotein(a)? Does 2-HOBA reduce markers of inflammation and blood clotting in the blood? Participants will: Take 2-HOBA capsules (400 mg, three times daily with meals) for 6 weeks Provide blood and urine samples at the beginning, middle, and end of the study Have lab tests to measure changes in lipids, inflammation, and clotting markers

Waitlist Available
Has No Placebo

Lipid Clinic at Brown University Health

Wenliang Song, MD

Have you considered Antivert clinical trials?

We made a collection of clinical trials featuring Antivert, we think they might fit your search criteria.
Go to Trials
Image of Sidney & Lois Eskenazi Hospital in Indianapolis, United States.

Composite Intervention for Metabolic Syndrome

18+
All Sexes
Indianapolis, IN

The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility. Participants (n=20) will be randomized to intervention or control (usual care). The composite intervention will include an educational video outlining the adverse effects of MetS and the benefit of walking, a written exercise prescription with a defined goal of walking 150 minutes per week, a Fitbit accelerometer device, resources for healthy eating practices, periodic text message reminders, and an urgent referral to primary care and our health system's Healthy Me clinic for follow-up visit. Investigators hypothesize that this approach will change patient understanding and motivation to increase physical activity and healthy eating habits.

Recruiting
Has No Placebo

Sidney & Lois Eskenazi Hospital

Image of Duke University Medical Center in Durham, United States.

Cardiometabolic Prevention Clinic for Cardiovascular Disease

18+
All Sexes
Durham, NC

This project is studying whether a team-based specialty clinic can help people with type 2 diabetes and heart disease better manage their blood pressure and cholesterol. The clinic includes coordinated care from heart doctors, kidney doctors, diabetes specialists, and liver doctors. The study will compare two groups of patients: one receiving usual care from their primary care provider, and one referred to the Duke Cardiometabolic Prevention Clinic for multidisciplinary care. The main goals are to find out if this clinic improves blood pressure and cholesterol control over 12 months, increases use of recommended heart medications, and reduces hospital visits and other healthcare use. Participants will be randomly assigned to one of the two groups. Those referred to the clinic will: 1) Meet with a cardiologist for an initial evaluation. 2) Be referred to other specialists (such as endocrinology, nephrology, or hepatology) based on their needs. 3) Receive ongoing, coordinated care from a team of specialists working together to improve their heart and metabolic health.

Recruiting
Has No Placebo

Duke University Medical Center

Neha J Pagidipati, MD, MPH

Image of University of Alabama at Birmingham in Birmingham, United States.

Inspire HER for Cardiovascular Disease

30 - 79
Female
Birmingham, AL

Poor heart health puts Black women at risk for a shorter life with more illness than people of any other non-indigenous racial group. We will refine and conduct a randomized, wait-list controlled trial of Inspire HER (a heart health lifestyle intervention for Black women that provides health education, physical activity, and social resources). We will also compare Inspire HER and Black Impact (a heart health intervention for Black men) data to study how women and men respond differently to stress. This trial aligns with American Heart Association's pledge to address heart health equity through new interventions that consider the person and the circumstances with which they live.

Recruiting
Has No Placebo

University of Alabama at Birmingham

Timiya S Nolan, PhD

Image of Rush University Medical Center in Chicago, United States.

Health Coaching for Heart Disease

40 - 75
All Sexes
Chicago, IL

The goal of this longitudinal study is to investigate the role of virtual health coaching on mitigation of cardiometabolic disease risk in an underserved, food insecure population. The main questions it aims to answer are: * Does longitudinal, individualized health coaching directed at lifestyle modification reduce patient 10-year risk of heart attack or stroke? * Does longitudinal, individualized health coaching directed at lifestyle modification reduce rates of hypertension, hyperlipidemia, and diabetes? * Does longitudinal, individualized health coaching directed at lifestyle modification improve accessibility to healthcare? Researchers will investigate the effects of regularly scheduled health coaching sessions on composite cardiometabolic risk profile as well as individual modifiable cardiovascular risk factors. Participants will: * Participate in in-person cardiovascular screening, occuring at the time of enrollment, months 3 and 6. * Engage in virtual health coaching sessions to talk about diet, exercise, weight loss, blood pressure and diabetes control, and accessibility to healthcare * Keep a log of their blood pressure

Waitlist Available
Has No Placebo

Rush University Medical Center

Daniel Luger, MD

Have you considered Antivert clinical trials?

We made a collection of clinical trials featuring Antivert, we think they might fit your search criteria.
Go to Trials